Anil Kumar Dedhia sells 8.5 lakh shares of Ganesh Benzoplast

Anil Kumar Dedhia has disposed of 8,50,000 shares of ganesh benzoplast via an open market transaction on May 20, 2026. The sale was disclosed to the stock exchanges under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Following the sale, the total equity share capital of the company remains unchanged at 7,19,89,421 shares of Re 1 each.

Prior to the transaction, Anil Kumar Dedhia held 33,36,000 shares, which accounted for 4.63% of the company's total paid-up share capital. The disposal of 8,50,000 shares, representing 1.18% of the capital, has reduced his stake to 24,86,000 shares. This revised holding constitutes 3.45% of the total voting capital of the company.

Shareholding Details

The disclosure outlines the shift in shareholding percentages for the acquirer and Persons Acting in Concert (PAC). The table below details the holdings before and after the transaction.

Name	Shareholding Before	% Before	Acquisition/Sale	Shareholding After	% After
Anil Kumar Dedhia	3336000	4.63	8,50,000	2486000	3.45
Sandhya Anil Dedhia	525000	0.73	0	525000	0.73
Anil V Dedhia (HUF)	95000	0.14	0	95000	0.14
Vasanji Shamji Dedhia (HUF)	45000	0.06	0	45000	0.06
Total	40,01,000	5.56		31,51,000	4.38

Transaction Overview

The transaction was executed exclusively through the open market mechanism. The seller does not belong to the promoter or promoter group of the company. The total diluted share capital of Ganesh Benzoplast Limited remains at 7,19,89,421 equity shares following the transaction. The shares of the company are listed on both the BSE Limited and the National Stock Exchange of India Limited.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.60%	+0.56%	+2.69%	+20.20%	-8.74%	+5.07%

Ganesh Benzoplast has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Wednesday, May 27, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was issued on May 18, 2025, and addressed to both BSE Limited and the National Stock Exchange of India Limited.

Board Meeting Details

The board meeting has been convened to consider and approve the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, as mandated under Regulation 33 of the Listing Regulations. The key details of the scheduled meeting are outlined below:

Parameter:	Details
Meeting Date:	Wednesday, May 27, 2026
Purpose:	Approval of Standalone & Consolidated Audited Financial Results
Period Under Review:	Quarter and Financial Year ended March 31, 2026
Regulatory Reference:	Regulation 29 & Regulation 33, SEBI (LODR) Regulations, 2015

Trading Window Closure

In accordance with the company's disclosure dated March 31, 2026, Ganesh Benzoplast has confirmed the closure of the Trading Window for dealing in the equity shares of the company. The closure applies to all designated persons and their immediate relatives, and the details are as follows:

Effective from: April 01, 2026
Closure continues until: 48 hours after the declaration of results on May 27, 2026

This measure is in compliance with applicable SEBI insider trading regulations, ensuring that restricted individuals are prohibited from transacting in the company's equity shares during the sensitive pre-results period.

Regulatory Compliance

The intimation was signed by Ekta Dhanda, Company Secretary of Ganesh Benzoplast, and submitted to the Department of Corporate Services – Corporate Relations Department at BSE Limited, as well as the Listing Department of the National Stock Exchange of India Limited. The filing underscores the company's adherence to its disclosure obligations under the SEBI Listing Regulations.